Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
Numerous personal experiences and psychosocial factors impacted participant motivations and capacity to continue LAIB post-release. Understanding and addressing these factors is necessary to support treatment retention and increase community-based program acceptability and continuation in this population.
Authors
- Adrian Dunlop (ORCID: https://orcid.org/0000-0003-2394-5966)
- Maja Lindegaard Moensted (ORCID: https://orcid.org/0000-0002-8708-1039)
- Jillian Roberts (ORCID: https://orcid.org/0000-0002-2429-2541)
- Samuel Lawson
- Bethany White (ORCID: https://orcid.org/0000-0002-2049-2669)
- Elizabeth McEntyre
- Paul Haber (ORCID: https://orcid.org/0000-0001-8915-8872)
- Michael Doyle (ORCID: https://orcid.org/0000-0003-2083-8575)
- Prof Nicholas Lintzeris
- Antoni Pazeski
- Lisa Maher
- Lucy J. D. Peck
Institutions
- The University of Sydney (AU)
- Burnet Institute (AU)
- IP Australia (AU)
- Australian Centre for HIV and Hepatitis Virology Research (AU)
- Sydney Local Health District (AU)
- South Eastern Sydney Local Health District (AU)
- Hunter New England Local Health District (AU)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1111/dar.70096
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00